Prof Kjetil Tasken speaking about the cost of CAR T-cells therapy and inequalities in cancer treatment

Prof. Kjetil Tasken, of Oslo University Hospital, joined us on December 17th for our Virtual Panel discussion that focused on Immuno-oncology: Exploring advances in developing Cancer Immunotherapies.

“I think many of the countries in Europe that have very good publicly funded healthcare systems have these problems with treatments being very expensive.”

You can watch the full discussion here.

Please feel free to share this...